Phospho-EPHA4 (Tyr596) Antibody

What is the significance of Tyr596 phosphorylation in EphA4 receptor signaling?

Tyr596 phosphorylation represents one of the earliest and most critical events in EphA4 receptor activation. Located in the juxtamembrane (JM) domain, this phosphorylation site plays a pivotal role in the conformational changes that activate the receptor's kinase functionality.

Methodologically, Tyr596 phosphorylation can be detected using specific antibodies that recognize only the phosphorylated form of this residue. This allows researchers to monitor EphA4 activation status in various experimental contexts. The phosphorylation of Tyr596 is particularly important because it enables the binding of SH2 domain-containing proteins, thereby initiating downstream signaling cascades involved in cell morphology modulation, adhesion regulation, and axonal guidance .

What applications can Phospho-EphA4 (Tyr596) antibodies be used for in research?

Phospho-EphA4 (Tyr596) antibodies have several validated research applications:

• Western Blotting: The primary application for detecting endogenous levels of EphA4 specifically when phosphorylated at Tyr596. Typically used at dilutions of 1:500-1:2000 .

• ELISA: Effective at higher dilutions (approximately 1:10000) for quantitative assessment of phosphorylation levels .

• Phosphorylation Dynamics Studies: Used to investigate temporal changes in EphA4 activation in response to various stimuli.

• Signaling Pathway Analysis: Helps decipher the role of EphA4 in developmental events, particularly in nervous system functioning .

• Complementary to FRET Biosensors: Can be used to validate results from FRET-based detection systems that monitor Tyr596 phosphorylation and subsequent binding to SH2 domains .

What sample types can be effectively analyzed using Phospho-EphA4 (Tyr596) antibodies?

Phospho-EphA4 (Tyr596) antibodies have demonstrated reactivity with the following sample types:

The antibodies specifically detect endogenous levels of EphA4 only when phosphorylated at Tyr596, making them valuable for studying activation states rather than total protein levels . When designing experiments, researchers should consider that EphA4 is ubiquitously expressed but particularly abundant in nervous system tissues .

How should researchers store and handle Phospho-EphA4 (Tyr596) antibodies to maintain reactivity?

Proper storage and handling of Phospho-EphA4 (Tyr596) antibodies is essential for maintaining their specificity and reactivity:

• Storage Temperature: Store at -20°C for up to one year from the date of receipt .

• Buffer Composition: Typically provided in PBS containing 50% glycerol, 0.5% BSA (or similar protein stabilizer), and 0.02-0.09% sodium azide at pH 7.4 .

• Aliquoting: Divide into small aliquots upon receipt to minimize freeze-thaw cycles.

• Thawing Protocol: Thaw on ice and mix gently by inversion rather than vortexing to prevent antibody denaturation.

• Working Dilutions: Prepare working dilutions on the day of use. For Western blot applications, dilutions typically range from 1:500 to 1:2000, while ELISA applications may use more dilute preparations (1:10000) .

Following these handling protocols will help ensure consistent experimental results and extend the useful life of the antibody.

How does the conformational dynamics of EphA4 change upon Tyr596 phosphorylation, and how can researchers study this?

Tyr596 phosphorylation induces significant conformational changes in the EphA4 receptor that are essential for its activation. Research has revealed several methodological approaches to studying these dynamics:

• Crystal Structure Analysis: Structural studies have shown that unphosphorylated Tyr596 in the juxtamembrane (JM) domain interacts with the kinase domain, maintaining the receptor in an autoinhibited state. Upon phosphorylation, this interaction is disrupted, allowing the activation segment to adopt an ordered conformation conducive to catalytic activity .

• Mutational Analysis: Experiments with Y596F mutants demonstrate the critical role of this residue, as such mutations prevent phosphorylation and maintain the receptor in an inactive state. Conversely, mutation of adjacent regulatory sites (such as Y750A) can rescue kinase activity even in the absence of JM phosphorylation, suggesting complex conformational relationships .

• FRET Biosensor Approaches: FRET-based detection systems have been developed to monitor Tyr596 phosphorylation and the subsequent binding to SH2 domains in real time. These biosensors typically include a substrate peptide from the EphA4 JM region containing Tyr596, which, upon phosphorylation, binds to an SH2 domain within the same construct, causing a conformational change that alters FRET signals .

• In vitro Phosphorylation Assays: These assays can measure the kinetics of Tyr596 auto-phosphorylation and how this affects subsequent catalytic activity toward other substrates, providing insights into the temporal aspects of conformational changes .

Understanding these conformational dynamics is crucial for developing therapeutic approaches targeting EphA4, particularly in contexts like Amyotrophic Lateral Sclerosis (ALS) where EphA4 modulation shows therapeutic potential .

What controls should be included when validating specificity of Phospho-EphA4 (Tyr596) antibodies in experimental design?

Rigorous validation of Phospho-EphA4 (Tyr596) antibodies requires multiple controls to ensure specificity and reliability:

• Phosphatase Treatment Control:

  • Treat duplicate samples with lambda phosphatase to dephosphorylate all phospho-tyrosine residues

  • This should eliminate the signal from phospho-specific antibodies, confirming phospho-dependence

• Site-Specific Mutation Controls:

  • Express wild-type EphA4 and Y596F mutant constructs in cellular systems

  • The Y596F mutation prevents phosphorylation at this specific site

  • Absence of signal with the mutant validates site-specificity

• Stimulation Controls:

  • Include both stimulated (ephrin ligand-treated) and unstimulated samples

  • Phosphorylation should increase upon receptor activation with appropriate ligands

• Peptide Competition Assay:

  • Pre-incubate antibody with the phosphorylated peptide immunogen

  • This should block specific binding and eliminate true positive signals

• Cross-Reactivity Assessment:

  • Test against other phosphorylated Eph receptors, particularly those with similar phosphorylation motifs

  • Also test against other tyrosine phosphorylated proteins to rule out non-specific recognition

• Kinase Inhibition Control:

  • Treat cells with tyrosine kinase inhibitors that affect EphA4

  • Should result in reduced phospho-signal, confirming relationship to kinase activity

These comprehensive controls help distinguish between true EphA4 Tyr596 phosphorylation and potential artifacts or cross-reactivity with other phosphorylated epitopes.

How does Tyr596 phosphorylation differ functionally from other phosphorylation sites on EphA4, and what experimental approaches can distinguish them?

EphA4 contains multiple phosphorylation sites with distinct functional roles. Tyr596 phosphorylation differs from other sites in several key aspects:

Experimental Approaches to Distinguish These Sites:

• Sequential Immunoprecipitation:

  • First IP with one phospho-specific antibody, then probe the supernatant with another

  • Helps determine if multiple sites are phosphorylated on the same molecule

• Phospho-peptide Mapping:

  • Mass spectrometry analysis of tryptic digests can identify which specific sites are phosphorylated

  • Particularly useful for quantifying relative phosphorylation levels across different sites

• Substrate Specificity Assays:

  • In vitro kinase assays with peptides containing different phosphorylation sites

  • Research has shown that EphA4 efficiently phosphorylates peptides containing Tyr596/Tyr610 motifs but not those with Tyr750 or Tyr788 motifs

• Mutational Analysis with Rescue Experiments:

  • Studies have demonstrated that Y750A mutation can rescue catalytic activity in Y596F/Y610F mutants

  • This indicates complex interactions between these phosphorylation sites

Understanding the distinct roles of these phosphorylation sites is crucial for interpreting experimental results and developing targeted interventions for EphA4-mediated pathologies.

How can researchers integrate Phospho-EphA4 (Tyr596) antibodies with FRET biosensors for comprehensive EphA4 activation studies?

Combining phospho-specific antibodies with FRET biosensors provides complementary approaches for studying EphA4 activation dynamics:

• Experimental Integration Strategy:

  • FRET biosensors offer real-time, live-cell visualization of Tyr596 phosphorylation events

  • Phospho-specific antibodies provide biochemical validation and quantification in fixed samples

  • Together, they provide both spatial-temporal dynamics and molecular specificity

• FRET Biosensor Design for EphA4:

  • Effective biosensors include a substrate peptide from the EphA4 JM region containing Tyr596

  • Upon phosphorylation, this peptide binds to an SH2 domain within the same construct

  • The conformational change alters the distance/orientation between fluorescent proteins (ECFP and YPet), changing FRET efficiency

  • Key controls include Y596F substrate peptide mutations and R175V SH2 domain mutations

• Validation Protocol:

  • Express FRET biosensor in cells of interest

  • Capture baseline FRET measurements

  • Stimulate with ephrin ligands or other activators

  • Monitor FRET changes in real time

  • Fix cells at specific timepoints and perform immunofluorescence with phospho-specific antibodies

  • Compare spatial patterns of activation detected by both methods

• Subcellular Localization Studies:

  • FRET biosensors reveal that EphA4 activation occurs in distinct membrane microdomains

  • Phospho-antibodies can confirm these findings in fixed cells using super-resolution microscopy

  • Combined approach helps distinguish between different pools of activated receptors

• Data Integration Approach:

  • Plot FRET ratio changes against antibody staining intensity for correlation analysis

  • Use computational methods to align temporal FRET data with fixed-cell antibody patterns

  • Create integrated maps of EphA4 activation across cellular compartments and over time

This integrated approach overcomes limitations of each individual method, providing robust validation and comprehensive insights into the spatial, temporal, and molecular aspects of EphA4 signaling.

What are the optimal experimental conditions for detecting phosphorylated Tyr596 in different cellular systems?

Optimizing detection of phosphorylated Tyr596 requires careful consideration of experimental conditions that vary across cellular systems:

• Cell Lysis Conditions:

  • Use ice-cold lysis buffer containing phosphatase inhibitors (sodium orthovanadate, sodium fluoride, β-glycerophosphate)

  • Include protease inhibitors to prevent degradation

  • Maintain a pH between 7.2-7.4 for optimal epitope preservation

  • Add 1% NP-40 or similar non-ionic detergent for membrane protein solubilization

• Stimulation Protocols:

  • For neuronal systems: 0.5-1 μg/ml pre-clustered ephrin ligands for 5-30 minutes

  • For overexpression systems: Serum starvation (4-6 hours) before stimulation enhances signal-to-noise ratio

  • For endogenous detection: Consider pre-treatment with pervanadate (100 μM, 15 min) to enhance phospho-tyrosine signals

• Sample Processing by Cell Type:

  Cell Type	Special Considerations
  Primary neurons	Gentle lysis, higher buffer-to-sample ratio, longer stimulation times
  Transfected cell lines	Expression level optimization, avoid toxic effects of overexpression
  Brain tissue	Rapid processing to prevent phosphatase activity, specialized homogenization

• Western Blot Conditions:

  • Use 7.5% gels for better resolution of high molecular weight EphA4 (~110 kDa)

  • Transfer to PVDF membranes (rather than nitrocellulose) for phospho-epitopes

  • Blocking with 5% BSA (not milk) in TBST to prevent phospho-epitope masking

  • Optimized antibody dilutions: 1:500-1:2000 range, incubate overnight at 4°C

• Signal Enhancement Strategies:

  • Immunoprecipitate EphA4 first, then probe with phospho-specific antibody

  • Use HRP-conjugated secondary antibodies with enhanced chemiluminescence

  • Consider tyramide signal amplification for low abundance phosphorylation

• Validation in Different Species:

  • Human and mouse samples show strong cross-reactivity with most commercial antibodies

  • Rat samples may require optimization of antibody concentration

These optimized conditions significantly improve detection sensitivity and specificity across experimental systems.

How do mutations at Tyr596 affect EphA4 function, and what experimental approaches can be used to study these effects?

Mutations at Tyr596 have profound impacts on EphA4 function, reflecting the central role of this phosphorylation site in receptor activation:

• Functional Consequences of Tyr596 Mutations:

  • Y596F mutation: Prevents phosphorylation, resulting in constitutively repressed kinase activity

  • This mutation blocks auto-phosphorylation and substrate phosphorylation activities in vitro

  • In cellular contexts, Y596F mutants fail to trigger downstream signaling events, even in the presence of ephrin ligands

• Experimental Approaches for Studying Y596 Mutants:

  A. Biochemical Assays:

  • Auto-phosphorylation Assays: Compare wild-type and Y596F mutant EphA4 proteins in in vitro kinase reactions

  • Substrate Phosphorylation Analysis: Measure phosphorylation of exogenous substrates like enolase

  • Continuous Spectrophotometric Assays: Quantify kinase activity using coupled enzyme systems

  B. Cellular Studies:

  • Transient Transfection: Express wild-type or Y596F mutant EphA4 in COS-1 or 293T cells

  • Immunoprecipitation: Isolate expressed proteins and assess phosphorylation status

  • Downstream Effector Activation: Monitor activation of Rho GTPases, MAPK pathways

  • Cell Morphology Analysis: Examine changes in cell shape, actin cytoskeleton, and adhesion properties

  C. Rescue Experiments:

  • Combined Mutations: Create double or triple mutants (e.g., Y596F+Y750A) to investigate compensatory mechanisms

  • Domain Swapping: Replace JM domain with constitutively active variants to bypass Tyr596 requirements

  • Pharmacological Rescue: Attempt to restore signaling in Y596F mutants using pathway modulators

  D. Structural Studies:

  • X-ray Crystallography: Compare conformations of wild-type and mutant kinase domains

  • NMR Analysis: Study dynamic interactions between JM domain and kinase domain

  • Molecular Dynamics Simulations: Model conformational changes influenced by Tyr596 phosphorylation status

• Physiological Relevance Assessment:

  • FRET Biosensor Adaptation: Modify existing FRET biosensors to incorporate Y596F mutation for live-cell studies

  • Knock-in Mouse Models: Generate Y596F knock-in mice to study developmental and physiological consequences

  • Primary Neuron Cultures: Express mutants in neurons to assess effects on axon guidance and synapse formation

These comprehensive experimental approaches provide insights into how Tyr596 phosphorylation controls EphA4 function at molecular, cellular, and physiological levels, with implications for understanding developmental processes and pathological conditions where EphA4 signaling is dysregulated.